Strategic News Watch • August 18, 2026 Daily Biopharma Digest – August 18, 2026 August 18, 2026 A pivotal Phase 3 win for Amylyx’s avexitide… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here